MARKET

NSPRZ

NSPRZ

INSPIREMD
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.2068
+0.0898
+76.75%
Pre Market: 0.2900 +0.0832 +40.23% 08:01 06/23 EDT
OPEN
0.3600
PREV CLOSE
0.1170
HIGH
0.3788
LOW
0.1700
VOLUME
251.09K
TURNOVER
--
52 WEEK HIGH
0.3788
52 WEEK LOW
0.0070
MARKET CAP
--
P/E (TTM)
-0.0155
1D
5D
1M
3M
1Y
5Y
BRIEF-InspireMD Announces Appointment Of Katie Arnold To Board
reuters.com · 05/12 10:09
BRIEF-InspireMD Announces First Quarter Loss Per Share Of $0.53
reuters.com · 05/11 11:45
BRIEF-InspireMD Announces Stock Exchange Listing Transfer To Nasdaq
reuters.com · 05/10 22:17
BRIEF-Inspiremd Appoints Acclaimed Interventional Cardiologist Kenneth Rosenfield, MD As Chair Of Its Newly Formed Scientific Advisory Board
reuters.com · 04/29 10:07
BRIEF-InspireMD Provides Corporate Update For Shareholders
reuters.com · 04/19 10:04
BRIEF-Inspiremd Announces 1-For-15 Reverse Stock Split
reuters.com · 04/14 20:25
BRIEF-Inspiremd Files Prospectus Related To Offering, Resale Of Up To 1.3 Mln Shares By Selling Stockholder
reuters.com · 04/05 20:17
BRIEF-InspireMD CEO Marvin Slosman Issues Letter To Stockholders
reuters.com · 03/22 11:56
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NSPRZ. Analyze the recent business situations of INSPIREMD through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
EPS
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.47%
Healthcare Equipment & Supplies
+0.78%
Key Executives
Chairman/Director
Paul Stuka
Chief Executive Officer/Director
Marvin Slosman
Vice Chairman/Director
Isaac Blech
Chief Financial Officer/Chief Administrative Officer/Treasurer/Secretary/IR Contact Officer
Craig Shore
Executive Vice President
Agustin Gago
Director
Kathryn Arnold
Director
Thomas Kester
Director
Gary Roubin
Independent Director
Michael Berman
Independent Director
Campbell Rogers
No Data
About NSPRZ
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

Webull offers kinds of InspireMD Inc stock information, including NASDAQ:NSPRZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NSPRZ stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NSPRZ stock methods without spending real money on the virtual paper trading platform.